# Project Plan

## Scope

End-to-end portfolio solution for FDA MAUDE reporting analytics with MedTech/PMS-oriented data quality, modeling, BI, validation, and synthetic quality workflow.

## Phase Roadmap

| Phase | Focus |
|---|---|
| 1 | Source assessment and baseline |
| 2 | Business requirements and user stories |
| 3 | Process maps and workflow design |
| 4 | Data dictionary and data model |
| 5 | Data-quality framework |
| 6 | Python ETL and validation |
| 7 | SQL analytics and Power BI model |
| 8 | Synthetic investigation/CAPA workflow |
| 9 | Testing, reconciliation and UAT |
| 10 | Portfolio presentation and release package |

## Design Principles

1. Preserve source lineage.
2. Keep report-level and device-level grains separate.
3. Never silently discard malformed records.
4. Reconcile critical KPIs independently.
5. Treat reporting increases as review candidates, not automatic safety conclusions.
6. Keep synthetic quality workflow data separate from FDA-derived data.
7. Document limitations, assumptions, versions and decisions.
